Bordeaux, Gironde, 33076, France
NCT Number: NCT00498784
HR-QoL and Sexuality in Mirena Inserted Contraception Users
The purpose of this study is to evaluate the changes in the quality of life, as well as in the sexual activity, in women inserted with MIRENA, a hormonal contraceptive intra-uterine system, over the first 12 months of use. Patients switching from oral contraception to an intrauterine contraceptive device (here: MIRENA) will be observed in the first year post MIRENA insertion.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–35 year
Sex eligibility
Female
Study type
Interventional
Phase
Phase 4
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Healthy woman willing to, or having to switch from her OC to another contraceptive method
Exclusion criteria
- Any contraindication to Mirena insertion/use
Treatment and study plan
Mirena
DrugMirena 52mg during 1 year
Primary outcomes
-
Health-related QoL score
Time frame: 1 year
Secondary outcomes
-
Sexuality Index, treatment satisfaction, usual safety outcomes
Time frame: 1 year
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Bayer
Industry
Registry information
Official study title
A Multicenter, Open Labelled, Uncontrolled, Phase IV Clinical Study to Evaluate the Health-related Quality of Life and Sexual Well-being in Young (18-35) Healthy Mirena Users Switching From OC, Over the First Year Post-insertion.
Important dates
- Study start
- 2005
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Jul 10, 2007
- Registry last updated
- Jan 23, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
NCT05139121
Contraception
Mobile, Alabama, United States
View Trial DetailsPilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception
NCT03067272
Contraception
New York, United States
View Trial DetailsIntervening on Women's Health for Rural Young Cancer Survivors
NCT06664034
Cancer, Contraception
Brawley, California, United States
View Trial DetailsThe HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
NCT05818254
Autoimmune Diseases, Connective Tissue Diseases
Chicago, Illinois, United States
View Trial Details